Results 141 to 150 of about 5,406 (200)

Ginger in supportive therapy against side effects of oncological treatment: a systematic review. [PDF]

BMC Complement Med Ther
Burg SC, Dörfler J, Büntzel J, Büntzel J, Huebner J.   +4 more
europepmc   +1 more source

Literature Review: Recent Therapeutic Advances in The Management of Prurigo Nodularis: From Conventional Therapy to Biologics and Targeted Small-Molecule Agents. [PDF]

Clin Cosmet Investig Dermatol
Avriyanti E, Larasati R, Rengasamy S, Hidayah RMN, Tsaqilah L, Pangastuti M, Maharani RH.   +6 more
europepmc   +1 more source

Aprepitant alleviates acute lung injury in a rat model of hepatic ischemia-reperfusion via NLRP3/IL-1β signaling pathway. [PDF]

Sci Rep
Abdelzaher WY, Kelleni MT, Adly MN, Attya ME, Fawzy MA, Ibrahim MA.   +5 more
europepmc   +1 more source

Potential risk of neoplasms with fezolinetant: clinical evidence, mechanisms, and post-marketing implications. [PDF]

J Endocr Soc
Boretti E, Dogné JM, Douxfils J.
europepmc   +1 more source

Three are better than two: redefining prophylaxis for postoperative nausea and vomiting. [PDF]

J Minim Invasive Surg
Kang H.
europepmc   +1 more source

Diagnostic and Therapeutic Potential of Substance P/NK1 Receptor in Primary Dysmenorrhea: A Pilot Study. [PDF]

Health Sci Rep
Mehboob R, Shahid I, Alzahrani AR, Yousof SM, Adnan H, Ekram SN, Alwazzan A, Nasief H, Khadawardi KA.   +8 more
europepmc   +1 more source

Exploring Potential Drug-Drug Interactions: A Cross-Sectional Study of 1 Million e-Prescriptions Across Medical Specialties in Shiraz, Iran (2021-2024). [PDF]

Iran J Med Sci
Porbaha P, Hasannejad M, Ahvar N, Shafiekhani M, Abolpour N, Sharifi M.   +5 more
europepmc   +1 more source

Olanzapine Use and Vomiting Incidence in Chemotherapy-receiving Patients With Cervical Cancer: Multicenter Post Hoc Analysis. [PDF]

In Vivo
Kawamura Y, Yoshida K, Morita H, Nakai M, Matsumoto T, Gohara Y, Hoshino N, Tonomura N, Banba M, Yamaguchi A, Tachibana M, Fukushima T, Hosokawa H, Mura T, Yabuki T, Watanabe S, Watanabe A, Sugiura M.   +17 more
europepmc   +1 more source

[Aprepitant and pruritus--comment].

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2013
openaire   +1 more source

Aprepitant

Hospital Pharmacy, 2003
Each month, subscribers to The Formulary Monograph Service receive five to six well-documented monographs on drugs that are newly released or are in late Phase III trials. The monographs are targeted to your Pharmacy and Therapeutics Committee. Subscribers also receive monthly one-page summary monographs on the agents that are useful for agendas and ...
Dennis J. Cada, Terri Levien, Danial E. Baker   +2 more
openaire   +2 more sources